Martha E. Linsenmeyer
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 3
- Pharmaceutical Science top 10%
-
- Epigenetics and DNA Methylation 3
- Cancer therapeutics and mechanisms 2
- CRISPR and Genetic Engineering 2
- Cancer-related gene regulation 2
-
- Bacteriophages and microbial interactions 2
-
- Genetics and Neurodevelopmental Disorders 2
-
- Chromosomal and Genetic Variations 2
Martha E. Linsenmeyer
13 papers receiving 543 citations
Peers
Comparison fields: 5 of 74
- Oncology 277
- Pharmaceutical Science 32
- Biomaterials 60
- Pharmacology 39
- Molecular Biology 276
Countries citing papers authored by Martha E. Linsenmeyer
This map shows the geographic impact of Martha E. Linsenmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha E. Linsenmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha E. Linsenmeyer more than expected).
Fields of papers citing papers by Martha E. Linsenmeyer
This network shows the impact of papers produced by Martha E. Linsenmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha E. Linsenmeyer. The network helps show where Martha E. Linsenmeyer may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Martha E. Linsenmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 12 | |
| 2 | 1998 | 10 | |
| 3 | 1998 | 29 | |
| 4 | Phase I trial of cremophor EL with bolus doxorubicin. | 1998 | 29 |
| 5 | 1997 | 31 | |
| 6 | 1997 | 125 | |
| 7 | 1994 | 2 | |
| 8 | 1994 | 6 | |
| 9 | 1993 | 121 | |
| 10 | 1991 | 35 | |
| 11 | 1991 | 9 | |
| 12 | 1991 | 2 | |
| 13 | Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. | 1990 | 149 |
About Martha E. Linsenmeyer
Martha E. Linsenmeyer is a scholar working on Biophysics, Molecular Biology and Oncology, having authored 13 papers that have together received 560 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer therapeutics and mechanisms (2 papers), Bacteriophages and microbial interactions (2 papers), CRISPR and Genetic Engineering (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Chromosomal and Genetic Variations (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Oncology (277 citations), Pharmaceutical Science (32 citations) and Biomaterials (60 citations). Martha E. Linsenmeyer has collaborated with scholars based in Australia and Germany. Frequent co-authors include D.M. Woodcock, J.P. Doherty, William Warren, P.J. Crowther, Michael Millward, Lorraine K. Webster, James F. Bishop, Grace Chojnowski, B T Williams and Ivan Bertoncello. Their work appears in journals such as Gene, Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute, British Journal of Cancer and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.